Leidos has been granted a patent for peptides with therapeutic applications including cancer inhibition, infectious disease treatment, vaccination response enhancement, sepsis treatment, and hair re-pigmentation. The patent claim specifies peptides with specific amino acid sequences. GlobalData’s report on Leidos gives a 360-degree view of the company including its patenting strategy. Buy the report here.
According to GlobalData’s company profile on Leidos, was a key innovation area identified from patents. Leidos's grant share as of May 2024 was 42%. Grant share is based on the ratio of number of grants to total number of patents.
Peptides for therapeutic purposes
A recently granted patent (Publication Number: US11987646B2) discloses a peptide with specific amino acid sequences, as well as an expression construct encoding this peptide. The patent further covers a pharmaceutical composition containing the peptide, a nucleic acid encoding the peptide, CAR-T cells expressing the peptide, or an oncolytic virus expressing the peptide, along with a pharmaceutically acceptable carrier. Additionally, the patent details the use of RNA as the nucleic acid, with specific modifications to enhance efficacy.
Moreover, the patent describes a method for inhibiting cancer progression, treating infectious diseases, enhancing vaccination responses, or treating sepsis by administering the pharmaceutical composition to individuals in need. The method allows for combination therapies, including cancer vaccines, CAR-T cell therapy, immune checkpoint inhibitors, cytokines, agonists of specific molecules, oncolytic viruses, and various therapeutic agents. Furthermore, the method extends to treating infectious diseases like malaria or hepatitis B, as well as using the peptide to address sepsis, showcasing the broad applicability of the patented technology in diverse medical conditions.
To know more about GlobalData’s detailed insights on Leidos, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.